Literature DB >> 22020834

Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy.

Carla Giordano1, Carlo Viscomi, Maurizia Orlandi, Paola Papoff, Alberto Spalice, Alberto Burlina, Ivano Di Meo, Valeria Tiranti, Vincenzo Leuzzi, Giulia d'Amati, Massimo Zeviani.   

Abstract

Ethylmalonic encephalopathy (EE) is a rare autosomal recessive disorder characterized by early onset encephalopathy, chronic diarrhoea, petechiae, orthostatic acrocyanosis and defective cytochrome c oxidase (COX) in muscle and brain. High levels of lactic, ethylmalonic and methylsuccinic acids are detected in body fluids. EE is caused by mutations in ETHE1, a mitochondrial sulphur dioxygenase. By studying a suitable mouse model, we found that loss of ETHE1 leads to accumulation of sulphide, which is a poison for COX and other enzymatic activities thus accounting for the main features of EE. We report here the first autopsy case of a child with a genetically confirmed diagnosis of EE, and compare the histological, histochemical and immunohistochemical findings with those of the constitutive Ethe1 (-/-) mice. In addition to COX depleted cells, widespread endothelial lesions of arterioles and capillaries of the brain and gastrointestinal tract were the pathologic hallmarks in both organisms. Our findings of diffuse vascular damage of target critical organs are in keeping with the hypothesis that the pathologic effects of ETHE1 deficiency may stem from high levels of circulating hydrogen sulphide rather than the inability of specific organs to detoxify its endogenous production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020834     DOI: 10.1007/s10545-011-9408-3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

1.  New clinical phenotype of branched-chain acyl-CoA oxidation defect.

Authors:  A Burlina; F Zacchello; C Dionisi-Vici; E Bertini; G Sabetta; M J Bennet; D E Hale; E Schmidt-Sommerfeld; P Rinaldo
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

2.  Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium.

Authors:  David C Dorman; Frederic J-M Moulin; Brian E McManus; Kristen C Mahle; R Arden James; Melanie F Struve
Journal:  Toxicol Sci       Date:  2002-01       Impact factor: 4.849

3.  Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells.

Authors:  Guangdong Yang; Lingyun Wu; Rui Wang
Journal:  FASEB J       Date:  2006-01-17       Impact factor: 5.191

4.  Ethylmalonic encephalopathy: further clinical and neuroradiological characterization.

Authors:  Salvatore Grosso; Rosa Mostardini; Maria Angela Farnetani; Massimo Molinelli; Rosario Berardi; Carlo Dionisi-Vici; Cristiano Rizzo; Guido Morgese; Paolo Balestri
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

5.  Clinical and neuropathological picture of ethylmalonic aciduria - diagnostic dilemma.

Authors:  Ewa Jamroz; Justyna Paprocka; Dariusz Adamek; Justyna Pytel; Katarzyna Szczechowska; Natalia Grabska; Michalina Malec; Ewa Głuszkiewicz; Michał Daab; Anatolij Wodołażski
Journal:  Folia Neuropathol       Date:  2011       Impact factor: 2.038

Review 6.  Signaling pathways for the vascular effects of hydrogen sulfide.

Authors:  Rui Wang
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-03       Impact factor: 2.894

Review 7.  Hydrogen sulphide and its therapeutic potential.

Authors:  Csaba Szabó
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

8.  Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences.

Authors:  J B Cavanagh; B N Harding
Journal:  Brain       Date:  1994-12       Impact factor: 13.501

9.  ETHE1 mutations are specific to ethylmalonic encephalopathy.

Authors:  V Tiranti; E Briem; E Lamantea; R Mineri; E Papaleo; L De Gioia; F Forlani; P Rinaldo; P Dickson; B Abu-Libdeh; L Cindro-Heberle; M Owaidha; R M Jack; E Christensen; A Burlina; M Zeviani
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

10.  Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein.

Authors:  Valeria Tiranti; Pio D'Adamo; Egill Briem; Gianfrancesco Ferrari; Rossana Mineri; Eleonora Lamantea; Hanna Mandel; Paolo Balestri; Maria-Teresa Garcia-Silva; Brigitte Vollmer; Piero Rinaldo; Si Houn Hahn; James Leonard; Shamima Rahman; Carlo Dionisi-Vici; Barbara Garavaglia; Paolo Gasparini; Massimo Zeviani
Journal:  Am J Hum Genet       Date:  2004-01-19       Impact factor: 11.025

View more
  18 in total

Review 1.  Mitochondrial adaptations to utilize hydrogen sulfide for energy and signaling.

Authors:  Kenneth R Olson
Journal:  J Comp Physiol B       Date:  2012-03-20       Impact factor: 2.200

2.  Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.

Authors:  Mustafa Kılıç; Özge Dedeoğlu; Rahşan Göçmen; Selman Kesici; Deniz Yüksel
Journal:  Metab Brain Dis       Date:  2016-11-09       Impact factor: 3.584

3.  Ethylmalonic acid induces permeability transition in isolated brain mitochondria.

Authors:  Cristiane Cecatto; Alexandre Umpierrez Amaral; Guilhian Leipnitz; Roger Frigério Castilho; Moacir Wajner
Journal:  Neurotox Res       Date:  2014-02-21       Impact factor: 3.911

4.  Stress response of OsETHE1 is altered in response to light and dark conditions.

Authors:  Charanpreet Kaur; Sneh Lata Singla-Pareek; Sudhir K Sopory
Journal:  Plant Signal Behav       Date:  2014

Review 5.  Hydrogen sulfide as an oxygen sensor.

Authors:  Kenneth R Olson
Journal:  Antioxid Redox Signal       Date:  2014-07-30       Impact factor: 8.401

Review 6.  Gastrointestinal and hepatic manifestations of mitochondrial disorders.

Authors:  Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

7.  The cysteine dioxgenase knockout mouse: altered cysteine metabolism in nonhepatic tissues leads to excess H2S/HS(-) production and evidence of pancreatic and lung toxicity.

Authors:  Heather B Roman; Lawrence L Hirschberger; Jakub Krijt; Alessandro Valli; Viktor Kožich; Martha H Stipanuk
Journal:  Antioxid Redox Signal       Date:  2013-03-19       Impact factor: 8.401

8.  Ethylmalonic encephalopathy associated with crescentic glomerulonephritis.

Authors:  Imad Dweikat; Enas Naser; Nadera Damsah; Bassam Abu Libdeh; Izzeddin Bakri
Journal:  Metab Brain Dis       Date:  2012-05-15       Impact factor: 3.584

9.  The mitochondrial sulfur dioxygenase ETHYLMALONIC ENCEPHALOPATHY PROTEIN1 is required for amino acid catabolism during carbohydrate starvation and embryo development in Arabidopsis.

Authors:  Lena Krüßel; Johannes Junemann; Markus Wirtz; Hannah Birke; Jeremy D Thornton; Luke W Browning; Gernot Poschet; Rüdiger Hell; Janneke Balk; Hans-Peter Braun; Tatjana M Hildebrandt
Journal:  Plant Physiol       Date:  2014-04-01       Impact factor: 8.340

10.  Severe early onset ethylmalonic encephalopathy with West syndrome.

Authors:  Laura Papetti; Giacomo Garone; Livia Schettini; Carla Giordano; Francesco Nicita; Paola Papoff; Massimo Zeviani; Vincenzo Leuzzi; Alberto Spalice
Journal:  Metab Brain Dis       Date:  2015-07-21       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.